Filter
261
Text search:
Good
Manufacturing
Practices
Featured
Recommendations
23
New Publications
56
Language
Document type
No document type
122
Studies & Reports
52
Guidelines
42
Strategic & Response Plan
23
Manuals
13
Training Material
4
Fact sheets
3
Situation Updates
2
Countries / Regions
Kenya
13
Ghana
12
Global
12
India
9
Western and Central Europe
7
Sierra Leone
6
Ethiopia
6
Zimbabwe
6
Uganda
5
Zambia
5
South–East Asia Region
5
Nepal
4
Tanzania
4
South Africa
4
Guinea
3
Nigeria
3
Philippines
3
Syria
3
Africa
3
Eastern Europe
3
Liberia
2
Senegal
2
Congo, Democratic Republic of
2
Rwanda
2
Malawi
2
Sudan
2
Ukraine
2
Botswana
2
East and Southern Africa
2
West and Central Africa
2
Asia
2
USA
1
Cameroon
1
Pakistan
1
South Sudan
1
Afghanistan
1
Cambodia
1
Bangladesh
1
Benin
1
Namibia
1
Lesotho
1
Myanmar / Burma
1
Sri Lanka
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Tajikistan
1
Russia
1
Moldova
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
94
Public Health
21
Key Resources
18
Pharmacy & Technologies
10
Clinical Guidelines
9
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
29
AMR
23
Pharmacy
20
Planetary Health
18
HIV
14
TB
11
Ebola & Marburg
7
Rapid Response
7
Mental Health
7
Disability
6
Global Health Education
6
Conflict
5
Health Financing Toolbox
5
Specific Hazards
4
NCDs
4
2.0 Rapid Response
4
Natural Hazards
3
Refugee
3
Caregiver
3
NTDs
2
Malaria
2
Cholera
1
Polio
1
Globally, approximately 56.8 million people are in need of palliative care
services; 78% of them living in low and middle-income country yet only
about 12% have their needs being met causing great suffering for many.
This report started with a simple question—“How can we tell how much funding is devoted to global health programs?”—and ended (more than two years later) with an answer that is far from simple. As those who have tried know well, tracking health-related funding is challenging in any setting,
...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa
...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin
...
2nd edition. The purpose of this document is to provide a generic model that can be used for risk assessment of larviciding and mollusciciding; it aims to harmonize the risk assessment of such pesticides for public health use. The assessment considers both adults and children (all age groups) as we
...
5th edition.
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of medicines for acute and chronic conditions as well as opinions and perceptio
...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdd
...
Second Edition
AIDS Medicines and diagnostics services
July 2015
The seventh WHO Report on the global tobacco epidemic analyses national efforts to implement the most effective measures from the WHO Framework Convention on Tobacco Control (WHO FCTC) that are proven to reduce demand for tobacco.
The report showed that while only 23 countries have implemented ce
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
